TGFB1 and cancer: This review focuses on the role of TGFβ1 dysregulation in cancer-associated immune suppression and highlights how our current understanding of TGFβ1-mediated tumor immune escape is driving therapeutic interventions to target this pathway in the treatment of cancer.